World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
45741
World Ranking
5763
National Ranking
3097

Overview

Carlos A. Perez is affiliated with The University of Texas Health Science Center at Houston in the United States. Their research primarily spans the field of Medicine, with a notable focus on several subfields including Pathology and Forensic Medicine, Neurology, Infectious Diseases, Physiology, and Cellular and Molecular Neuroscience.

The scientist's major research topics encompass multiple sclerosis and related neurological disorders. Key areas include:

  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Long-Term Effects of COVID-19
  • Hereditary Neurological Disorders
  • Histiocytic Disorders and Treatments
  • Autoimmune Neurological Disorders and Treatments
  • COVID-19 Clinical Research Studies

Recent publications by Carlos A. Perez span from 2020 to 2022 and cover multiple sclerosis, clinical neurological assessments, racial and ethnic disparities in treatment, and the impact of COVID-19 on neurological outcomes. Selected papers include:

  • Looking ahead (2020), Neurology Clinical Practice
  • Racial and ethnic disparities in treatment response and tolerability in multiple sclerosis: A comparative study (2021), Multiple Sclerosis and Related Disorders
  • Assessment of Racial/Ethnic Disparities in Volumetric MRI Correlates of Clinical Disability in Multiple Sclerosis: A Preliminary Study (2020), Journal of Neuroimaging
  • COVID-19 severity and outcome in multiple sclerosis: Results of a national, registry-based, matched cohort study (2021), Multiple Sclerosis and Related Disorders
  • Immunopathogenesis, Diagnosis, and Treatment of Multiple Sclerosis (2022), Neurologic Clinics

Frequent publication venues where their work has appeared include:

  • Neurology
  • Neurology International
  • Cureus
  • Multiple Sclerosis and Related Disorders
  • Neurosurgery

Carlos A. Perez collaborates regularly with a group of frequent co-authors, including:

  • John A. Lincoln
  • Rajesh Gupta
  • Anam Haque
  • Thejasvi A. Reddy
  • Christopher Orlando

Best Publications

  • Principles and practice of radiation oncology

    Carlos A. Perez;Luther W. Brady

  • Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)

    Mary V Graham;James A Purdy;Bahman Emami;William Harms

  • Principles and Practice of Gynecologic Oncology

    William J. Hoskins;Carlos A. Perez;Robert C. Young

  • The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group

    Bruce Borgelt;Richard Gelber;Simon Kramer;Luther W. Brady

  • Long‐term observations of the patterns of failure in patients with unresectable non‐oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group

    Carlos A. Perez;Thomas F. Pajak;Philip Rubin;Joseph R. Simpson

  • A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results

    K.S.Clifford Chao;Joseph O Deasy;Jerry Markman;Joyce Haynie

  • Phase III Trial of Neoadjuvant Chemotherapy in Patients With Invasive Bladder Cancer Treated With Selective Bladder Preservation by Combined Radiation Therapy and Chemotherapy: Initial Results of Radiation Therapy Oncology Group 89-03

    W.U. Shipley;K.A. Winter;D.S. Kaufman;W.R. Lee

  • A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the radiation therapy oncology group

    C. A. Perez;K. Stanley;P. Rubin;S. Kramer

  • Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706

    Colleen A. Lawton;Minhee Won;Miljenko V. Pilepich;Sucha O. Asbell

  • A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.

    K.S.Clifford Chao;Walter R Bosch;Sasa Mutic;Jason S Lewis

  • Factors influencing cosmetic results after conservation therapy for breast cancer

    Marie E. Taylor;Carlos A. Perez;Karen J. Halverson;Robert R. Kuske

  • Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: report by the Radiation Therapy Oncology Group.

    Carlos A. Perez;Kenneth Stanley;Graham Grundy;William Hanson

  • Carcinoma of the uterine cervix. I: Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy

    Carlos A. Perez;Perry W. Grigsby;Hernan Castro-Vita;Mary Ann Lockett

  • Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.

    William U. Shipley;Howard D. Thames;Howard M. Sandler;Gerald E. Hanks

  • Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.

    Steven DuBois;Yan Kalika;John Lukens;Garrett Brodeur

  • Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques.

    K. S Clifford Chao;Navneet Majhail;Chih Jen Huang;Joseph R. Simpson

  • Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications.

    Carlos A. Perez;Sherry Breaux;John M. Bedwinek;Hywel Madoc-Jones

  • Impact of tumor control on survival in carcinoma of the lung treated with irradiation

    Carlos A. Perez;Madeline Bauer;Sharon Edelstein;Brenda W. Gillespie

  • Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone

    Carlos A. Perez;Perry W. Grigsby;Shriram M. Nene;H. Marvin Camel

  • Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.

    J. Gershon Spector;Donald G. Sessions;Bruce H. Haughey;K. S. Clifford Chao

Frequent Co-Authors

Perry W. Grigsby
Perry W. Grigsby Washington University in St. Louis
Jeff M. Michalski
Jeff M. Michalski Washington University in St. Louis
James D. Cox
James D. Cox The University of Texas MD Anderson Cancer Center
Mack Roach
Mack Roach University of California, San Francisco
Thomas F. Pajak
Thomas F. Pajak RTOG Foundation
Jeannette Y. Lee
Jeannette Y. Lee University of Arkansas for Medical Sciences
Howard M. Sandler
Howard M. Sandler Cedars-Sinai Medical Center
Mark E. Nesbit
Mark E. Nesbit University of Minnesota
David G. Mutch
David G. Mutch Washington University in St. Louis
William U. Shipley
William U. Shipley Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine opens up a variety of pathways beyond traditional MD programs. Today, students can access high-quality, flexible online degrees in healthcare, allowing them to specialize and advance their careers without stepping away from their current responsibilities.

For those seeking leadership roles in healthcare, cheapest mha programs online healthcare provide an affordable route to a master’s degree in healthcare administration. Nurses can move into specialized or advanced practice with cheapest bsn to dnp programs, enabling them to earn a Doctor of Nursing Practice online.

If you are interested in pharmaceuticals, there are flexible pharmacy school online accredited options available to support your journey to becoming a pharmacist. Additionally, the growth of digital health records has fueled demand for professionals with expertise from health information technology programs online, making it a promising interdisciplinary field.

Each of these online degrees offers a pathway to rewarding roles in the expanding healthcare industry, with options suitable for various budgets and schedules.

Best Scientists Citing Carlos A. Perez

Trending Scientists